Does OBINUTUZUMAB Cause Hypersensitivity? 160 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 160 reports of Hypersensitivity have been filed in association with OBINUTUZUMAB (Gazyva). This represents 1.1% of all adverse event reports for OBINUTUZUMAB.
160
Reports of Hypersensitivity with OBINUTUZUMAB
1.1%
of all OBINUTUZUMAB reports
57
Deaths
75
Hospitalizations
How Dangerous Is Hypersensitivity From OBINUTUZUMAB?
Of the 160 reports, 57 (35.6%) resulted in death, 75 (46.9%) required hospitalization, and 5 (3.1%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which OBINUTUZUMAB Alternatives Have Lower Hypersensitivity Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE